We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Exco InTouch, Pharma’s Only Representative on Sunday Times Hiscox Tech Track 100

News   Sep 12, 2015

 
Exco InTouch, Pharma’s Only Representative on Sunday Times Hiscox Tech Track 100
 
 
Advertisement
 

RELATED ARTICLES

CAR T-Cell Therapy Shows Promising Early Results in Children With Neuroblastoma

News

A novel CAR T-cell therapy has shown promising early results in children with neuroblastoma, a rare form of childhood cancer. Twelve children with relapsed or refractory neuroblastoma were treated as part of a Phase I clinical trial.

READ MORE

Oxford's COVID-19 Vaccine Has 70% Efficacy Rate

News

There are now over 170 teams of researchers working to develop a vaccine for protection against COVID-19. Over the last few weeks, a number of groups shared interim analysis data on candidates that have reached Phase III clinical testing. The latest addition is the University of Oxford – in collaboration with the pharmaceutical company AstraZeneca – who today announce an efficacy of 70.4% for the candidate, ChAdOx1 nCoV-2019.

READ MORE

Two Targeted Therapies Developed for Idiopathic Pulmonary Fibrosis

News

A new treatment option for lung fibrosis is being developed by Purdue University scientists.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE